ACIS ResearchAI文明投资研究院Contact ACIS RESEARCH MEMO
When the evidence changes,
we record how our judgment changes.
Short research notes on meaningful shifts in market structure, industry evidence and investment frameworks—not daily calls on price direction.
PARALLEL ARCHIVES · PRODUCT NAVIGATION
You are viewing Research Memos
Special Update
Which event needs a deeper answer?Research Memo
How did new evidence change our thesis?This archive contains only thesis-change records, not routine event coverage.
DECISION JOURNAL
Every memo preserves one judgment path
A useful memo does not merely state a view. It makes the update auditable.
- 01Previous view
What did we believe before the new evidence arrived?
- 02New evidence
Which data, event or market structure actually changed?
- 03Judgment update
What changed—and what did not?
- 04Next verification
What would confirm, weaken or overturn the updated view?
RESEARCH MEMOS
Published memos and current candidates
Published memos have passed evidence review. Candidates remain unpublished research notes.
Google and Microsoft Forecast Archive: Cloud Growth Must Pass the Cash-Return Test
A historical baseline compiled on 29 October, with unchanged ranges, no backdating and no actual results.
Read full memo ↗The AI Buildout Enters a Capital-Efficiency Test: Energy, Credit, Earnings and Four Market Scenarios
Separate energy shocks, capital constraints and AI cash conversion through four conditional scenarios.
Read full memo ↗AI Infrastructure Expansion Still Depends on External Funding
CRWV, NBIS and IREN did not cover defined cash capital expenditure with first-half operating cash flow; advance receipts support liquidity but do not remove fulfillment and refinancing obligations.
Read full memo ↗Palantir's UK Procurement Friction Rises, but Revenue Loss Is Not Yet Proven
Two committees, more than 44,000 objections and the Met procurement dispute push governance risk into renewal and new-award decisions; NHS termination, £330m of revenue and measurable cash-flow damage remain unproven.
Read full memo ↗Starship Crosses the Orbital Payload Threshold, but Repeat Reliability Remains Unproven
Flight 14 reached orbit and deployed 26 Starlink V3 satellites, materially lifting engineering readiness. The engine anomaly, consecutive success, reuse and unit economics remain unproven.
Read full memo ↗Microsoft Turns Agent Work into a Metered Service as Enterprise AI Adds Usage Billing to Seats
Microsoft keeps the USL as the fixed-price access layer while Cowork, Code, Autopilot and frontier models consume Copilot Credits. The architecture strengthens; revenue, margin and free cash flow remain unproven.
Read full memo ↗Stablecoins Move Beyond Pilots as SoFiUSD Goes Live and Citi Connects Enterprise Payments
SoFiUSD is live in card-program settlement, while Citi and Coinbase connect stablecoins to enterprise acceptance and virtual accounts. The thesis moves to partial production settlement; volume and economics remain unproven.
Read full memo ↗Texas Data Center Permit Pause: Execution Quality and the AI Credit Cycle
AI demand remains intact, but announced GW must clear permits, power, contracts, construction, funding and commercialization. The revenue clock can slip while the interest clock keeps running.
Read full memo ↗Tempus × Recursion: Data Moat Becomes Contracted — Not Yet a Cash Moat
Committed payments improve contract visibility, while the lower ceiling and three-year term leave pricing power, revenue recognition and cash conversion to be proven.
Read full memo ↗Tokenized Finance Is Entering Regulated Market Infrastructure
The SEC has opened a limited secondary-trading path for eligible tokenized NMS stock, while Eurosystem Pontes connects wholesale tokenized assets to central-bank-money settlement. Institutionalization is advancing; commercial revenue still needs proof.
Read full memo ↗Insilico Gains Commercial and Market Validation, but Clinical Proof Is Still the Next Gate
Revenue, profitability, operating cash flow and clinical progress strengthen the thesis; repeatable milestone revenue and Phase III success still determine long-term value.
Read full memo ↗Agility Digit 5 Enters Auditable Operations
Named customers, field hours, task volume and accuracy strengthen the humanoid-commercialization thesis; conditional orders still require delivery, acceptance, revenue and ROI proof.
Read full memo ↗The Next Bottleneck in AI Infrastructure: The Cost of Capital
AI construction needs cash flows that cover financing costs as well as chips, power and demand. Capital costs are becoming a structural constraint; more debt alone does not establish a systemic crisis.
Read full memo ↗Circle Is Not Just Buying a Payments Firm—USDC Is Acquiring Its Own Cross-Border Distribution Network
Circle’s proposed Tazapay acquisition adds banking connectivity, local payout and existing cross-border flow to USDC. The thesis strengthens; closing, retention, USDC mix and profit conversion remain unproven.
Read full memo ↗Slower Frontier AI Does Not Mean Peak AI
More cautious frontier development is not evidence that AI demand has peaked. ACIS sees competition broadening from capability alone to reliability, control and distribution, with safety becoming a condition for commercial scale.
Read full memo ↗Figure Is Evolving from Onchain Lending into an AI-Enabled RWA Capital-Markets Platform
Figure Connect, Kiavi and Sierra agents bring assets, partners, distribution and loan conversion into one network. The platform thesis strengthens; replication and credit quality remain unproven.
Read full memo ↗AI Financing Moves Beyond GPU Collateral as Contract Quality Sets the Cost of Capital
Capital remains available for AI infrastructure, but customer credit, contract duration, cash-flow coverage and re-leasing risk now directly determine funding costs.
Read full memo ↗Google Signs a 22-Year Nuclear PPA: AI Companies Begin Financing Power Assets
The PPA converts AI demand into financeable long-duration cash flow for nuclear life extension, grids, storage and new generation, strengthening the contracted-power thesis.
Read full memo ↗Rentosertib Shows a Human Signal: AI Drug Discovery Takes Another Step Toward Clinical Validation
An AI-designed drug has produced an exploratory human biomarker signal that strengthens the research thesis. Small-sample aging-clock changes do not establish longer life, clinical benefit or a clinical breakthrough.
Read full memo ↗IonQ Unveils 256-Qubit Superion: Productization Accelerates, Revenue Purity Declines
Superion 256 becomes orderable. Manufacturing and productization rise, while performance, delivery and compute-revenue separation remain unproven; maturity stays 73/100.
Read full memo ↗TAO’s Trend Is Confirmed—And That Is Precisely Why Not to Chase
TAO moves from Recovery to Trend Confirmed. Hold existing positions, wait for consolidation with new capital, and validate $237–240 support plus real Subnet demand.
Read full memo ↗Quantum Computing’s Next Core Metric: Why Throughput May Matter More Than Qubit Count
IBM Nighthawk r2 moves from a hardware milestone to real cloud access: engineering maturity rises; fault tolerance and commercial proof do not.
Read full memo ↗Oil Is Back Above $90: A Real Supply Shock or Another Geopolitical Premium?
Transport disruption and thin product inventories raise near-term supply risk, but oil has not replaced infrastructure as the core AI-energy thesis.
Read full memo ↗HSBC, Standard Chartered or Ping An: Which Is Better for Long-Term Holding?
Three Financial Quality Value paths compared across earnings, capital returns, valuation and portfolio role.
Read full memo ↗NOW | How far has enterprise AI workflow monetization progressed?
AI ACV, subscription revenue and backlog validate scaled commercialization. Classify under Growth Leaders; keep on core watch for better odds.
Read full memo ↗The AI software rally may have started—but this will not be a broad SaaS rebound
MSFT distribution, PLTR/NOW deployment and CRM/CRWD/FIG diffusion validate selective re-rating.
Read full memo ↗What does semiconductor crowding falling from 82% to 53% really mean?
De-crowding is not the end of the AI cycle. The next test is whether CapEx, orders, backlog and credit weaken together.
Read full memo ↗Is phase one of AI over? From ‘everything AI rises’ to cash flow deciding valuation
Markets are beginning to price self-funded, profitable and financing-dependent AI businesses differently.
AI Cycle · Cash Flow · ValuationMoney is leaving semiconductors but still overweighting tech. Where is it going?
Track rotation from semiconductor beta into AI quality, software commercialization and selected low-consensus sectors.
Capital Rotation · AI Quality · CommercializationIs healthcare becoming the next low-consensus alpha?
Apply our five-layer filter: industry tailwind, low consensus, improving fundamentals, fund flows and valuation.
Healthcare · Alpha · FlowsWhy are we not rushing to buy the SOXX dip?
Do not guess the bottom. Locate the cycle, then manage uncertainty through staging and position sizing.
Read full memo ↗FROM CONVERSATION TO RESEARCH
A valuable thought should not disappear after the conversation ends.
A research memo is published only after the underlying evidence, uncertainty, decision boundary and human review are complete.
Return to Research Center